Evidence map›Paper›PMID 36521802›Full record

Observational studyThe Journal of allergy and clinical immunology2023

Defining the window of opportunity and target populations to prevent peanut allergy.

Graham Roberts, Henry T Bahnson, George Du Toit, Colin O'Rourke, Michelle L Sever, Erica Brittain, Marshall Plaut, Gideon Lack

Registry-linked trialOpen access · hybridAbstract readObservational Study
In one paragraph

Observational study in The Journal of allergy and clinical immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00329784 (Induction of Tolerance Through Early Introduction of Peanut in High-Risk Children), which is not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00329784 phase2completednot on this map

Induction of Tolerance Through Early Introduction of Peanut in High-Risk Children (ITN032AD)

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2006 to 2014Enrolled640ConditionsEczema, Egg Allergy, Food AllergyArmsPeanut Consumption Group
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. ASCIA Guideline: Infant Feeding for Food Allergy Prevention.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Guideline
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Dietary Antigen Interaction with Intestinal Epithelial Cells.Current allergy and asthma reports · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease.The journal of allergy and clinical immunology. In practice · 2025
    Review
  14. Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT).Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Primary prevention of food allergy: beyond early introduction.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Graham RobertsUniversity of Southampton and Southampton NIHR Biomedical Research Centre, Southampton, and the David Hide Centre, Isle of Wight, United Kingdom.
Henry T BahnsonBenaroya Research Institute and the Immune Tolerance Network, Seattle, Wash.
George Du ToitPediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College, and the Children's Allergy Service, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Colin O'RourkeBenaroya Research Institute and the Immune Tolerance Network, Seattle, Wash.
Michelle L SeverRho Federal Systems Division, Durham, and PPD Government and Public Health Services, Wilmington, NC.
Erica BrittainNational Institute of Allergy and Infectious Diseases, Bethesda, Md.
Marshall PlautNational Institute of Allergy and Infectious Diseases, Bethesda, Md.
Gideon LackPediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College, and the Children's Allergy Service, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Electronic address: gideon.lack@kcl.ac.uk.
Guy's and St Thomas' NHS Foundation Trust · GBImmune Tolerance Network · USNational Institute of Allergy and Infectious Diseases · USRho (United States) · USUniversity of Southampton · GB

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
IMMUNE TOLERANCE NETWORK-266015416-266015416N01AI015416 · NIAID · REGENTS OF THE UNIVERSITY OF C · PI BLUESTONE, JEFFREY A · 2002 to 2006
–
Department of Health NIHRCS/01/2008/009Medical Research Council MC_G1001205NIAID NIH HHS HHSN272200800029CNIAID NIH HHS N01 AI015416NIAID NIH HHS UM1 AI109565NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

backgroundPeanut allergy affects 1% to 2% of European children. Early introduction of peanut into the diet reduces allergy in high-risk infants.

objectiveWe aimed to determine the optimal target populations and timing of introduction of peanut products to prevent peanut allergy in the general population.

methodsData from the Enquiring About Tolerance (EAT; n = 1303; normal risk; 3-year follow-up; ISRCTN14254740) and Learning Early About Peanut Allergy study (LEAP; n = 640; high risk; 5-year follow-up; NCT00329784) randomized controlled trials plus the Peanut Allergy Sensitization (PAS; n = 194; low and very high risk; 5-year follow-up) observational study were used to model the intervention in a general population. Peanut allergy was defined by blinded peanut challenge or diagnostic skin prick test result.

resultsTargeting only the highest-risk infants with severe eczema reduced the population disease burden by only 4.6%. Greatest reductions in peanut allergy were seen when the intervention was targeted only to the larger but lower-risk groups. A 77% reduction in peanut allergy was estimated when peanut was introduced to the diet of all infants, at 4 months with eczema, and at 6 months without eczema. The estimated reduction in peanut allergy diminished with every month of delayed introduction. If introduction was delayed to 12 months, peanut allergy was only reduced by 33%.

conclusionsThe preventive benefit of early introduction of peanut products into the diet decreases as age at introduction increases. In countries where peanut allergy is a public health concern, health care professionals should help parents introduce peanut products into their infants' diet at 4 to 6 months of life.

Indexed as

EczemaPeanut HypersensitivityAllergensArachisChildDietHumansInfantRandomized Controlled Trials as TopicRiskAllergensdietearly introductionPeanut allergypopulationprevention

Identifiers

PMID36521802
PMCPMC10689252
OpenAlexW4311668375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.